These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7798493)

  • 1. Evidence for reduction of norepinephrine uptake sites in the failing human heart.
    Böhm M; La Rosée K; Schwinger RH; Erdmann E
    J Am Coll Cardiol; 1995 Jan; 25(1):146-53. PubMed ID: 7798493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmural heterogeneity of norepinephrine uptake in failing human hearts.
    Beau SL; Saffitz JE
    J Am Coll Cardiol; 1994 Mar; 23(3):579-85. PubMed ID: 8113537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M; Mittmann C; Schwinger RH; Erdmann E
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
    Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
    Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
    Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
    J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
    Schwinger RH; Böhm M; Schulz C; Schmidt U; Schmidt U; Schmid B; Dienemann H; Reichart B; Erdmann E
    J Pharmacol Exp Ther; 1993 Apr; 265(1):346-57. PubMed ID: 8386240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
    Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
    Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium.
    Flesch M; Schwinger RH; Schiffer F; Frank K; Südkamp M; Kuhn-Regnier F; Arnold G; Böhm M
    Circulation; 1996 Sep; 94(5):992-1002. PubMed ID: 8790037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
    Bristow MR; Ginsburg R; Umans V; Fowler M; Minobe W; Rasmussen R; Zera P; Menlove R; Shah P; Jamieson S
    Circ Res; 1986 Sep; 59(3):297-309. PubMed ID: 2876788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
    Müller-Ehmsen J; Brixius K; Schwinger RH
    J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle.
    Parker JD; Newton GE; Landzberg JS; Floras JS; Colucci WS
    Circulation; 1995 Oct; 92(7):1793-800. PubMed ID: 7671363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium.
    Schwinger RH; Böhm M; Pieske B; Erdmann E
    Eur J Clin Invest; 1991 Aug; 21(4):443-51. PubMed ID: 1657613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations.
    Danielsen W; v der Leyen H; Meyer W; Neumann J; Schmitz W; Scholz H; Starbatty J; Stein B; Döring V; Kalmár P
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):171-3. PubMed ID: 2475709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium.
    Hershberger RE; Feldman AM; Bristow MR
    Circulation; 1991 Apr; 83(4):1343-51. PubMed ID: 1901530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats.
    Backs J; Bresch E; Lutz M; Kristen AV; Haass M
    Cardiovasc Res; 2005 Aug; 67(2):283-90. PubMed ID: 16005303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts.
    Linck B; Boknik P; Knapp J; Müller FU; Neumann J; Schmitz W; Vahlensieck U
    Br J Pharmacol; 1996 Oct; 119(3):545-50. PubMed ID: 8894176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.